p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines.
Toll-like receptors (TLRs) are important sensors of microbial pathogens and mediators of innate immune responses. Although the signal transduction of TLRs is well elucidated, their basal regulation is largely unexplored. Here we show that the tumor suppressor p53 positively regulates the transcription of TLR3, a receptor for viral double-stranded RNA and poly(I-C), by binding to the p53 site in the TLR3 promoter. TLR3 expression was lower in HCT116 p53(-/-) cells than in HCT116 p53(+/+) cells. Activation of p53 by 5-fluorouracil increased the TLR3 mRNA in epithelial cell lines with wild-type p53 but not in cell lines harboring mutant p53. Knockdown of p53 by small interfering RNA decreased the TLR3 expression. TLR3 mRNA was also lower in liver and intestine of p53(-/-) mice than in p53(+/+) mice. Furthermore, the poly(I-C)-induced phosphorylation of IkappaB-alpha, nuclear translocation of NF-kappaB, and phosphorylation of interferon regulatory transcription factor 3, were drastically reduced in HCT116 p53(-/-) cells, indicating a dysregulation of the two signaling pathways governed by TLR3. Consequently, induction of interleukin-8 and beta interferon after poly(I-C) stimulation was impaired in HCT116 p53(-/-) cells. These results suggest that p53 influences TLR3 expression and function and highlight a role of p53 in innate immune response in epithelial cells.
Taura
Manabu
M
Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.
Eguma
Ayaka
A
Suico
Mary Ann
MA
Shuto
Tsuyoshi
T
Koga
Tomoaki
T
Komatsu
Kensei
K
Komune
Takefumi
T
Sato
Takashi
T
Saya
Hideyuki
H
Li
Jian-Dong
JD
Kai
Hirofumi
H
D000818:Animals; D045744:Cell Line, Tumor; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D051379:Mice; D011070:Poly I-C / Q000494:pharmacology; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D051196:Toll-Like Receptor 3 / Q000235:genetics* / Q000378:metabolism; D015533:Transcriptional Activation / Q000187:drug effects; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
D016207:Cytokines; D012333:RNA, Messenger; D051196:Toll-Like Receptor 3; D016159:Tumor Suppressor Protein p53; D011070:Poly I-C
J Virol. 2005 Jul;79(14):8802-11
15994774
FEBS Lett. 1997 Apr 14;406(3):234-42
9136893
Immunology. 2005 Aug;115(4):565-74
16011525
J Immunol. 2007 Sep 1;179(5):2741-7
17709487
Expert Rev Mol Med. 2003 Nov 19;5(28):1-16
14987403
Exp Mol Med. 2007 Aug 31;39(4):421-38
17934330
Rev Med Virol. 2004 Sep-Oct;14(5):301-19
15334538
Nat Rev Mol Cell Biol. 2008 May;9(5):402-12
18431400
Adv Drug Deliv Rev. 2008 Apr 29;60(7):805-12
18262679
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8467-72
12077306
Science. 2004 Mar 5;303(5663):1529-31
14976261
J Biol Chem. 2004 Apr 30;279(18):19091-8
14976184
FASEB J. 2006 Apr;20(6):782-4
16478769
Clin Microbiol Rev. 2008 Jan;21(1):13-25
18202435
Nature. 2003 Jul 31;424(6948):516-23
12872134
Nature. 2006 Jul 6;442(7098):39-44
16823444
Nat Rev Mol Cell Biol. 2007 Apr;8(4):275-83
17380161
Br J Cancer. 2006 Jan 30;94(2):318-22
16421597
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8459-64
16714379
Science. 2004 Mar 5;303(5663):1526-9
14976262
Oncogene. 1995 Nov 16;11(10):1939-46
7478511
Nature. 2001 Oct 18;413(6857):732-8
11607032
BMC Infect Dis. 2007 Nov 19;7:136
18021446
Cancer Res. 2002 Nov 15;62(22):6579-86
12438253
Oncogene. 1993 Dec;8(12):3313-22
7504233
J Virol. 2005 Sep;79(17):11105-14
16103161
Cell. 2006 Feb 24;124(4):783-801
16497588
Mol Cell Biol. 2007 May;27(10):3732-42
17353266
Int Arch Allergy Immunol. 2007;143 Suppl 1:80-3
17541283
Oncogene. 2005 Apr 21;24(18):3059-62
17726827
Nature. 2005 Aug 18;436(7053):939-45
16107833
J Gastroenterol Hepatol. 2007 Oct;22(10):1627-32
17845690
Biochem Biophys Res Commun. 2005 Jun 10;331(3):701-6
15865925
Nature. 2006 May 4;441(7089):101-5
16625202
J Biol Chem. 2003 May 9;278(19):16713-9
12609980
J Gen Virol. 2008 May;89(Pt 5):1106-1113
18420787
J Immunol. 2007 Oct 15;179(8):5425-32
17911629
Nat Immunol. 2006 Feb;7(2):131-7
16424890
Biochem Biophys Res Commun. 2003 Nov 7;311(1):39-48
14575692
Mol Biol Cell. 2006 Apr;17(4):1583-92
16436515
Cell. 2008 Feb 8;132(3):344-62
18267068
Annu Rev Biochem. 2008;77:557-82
18410249
Curr Top Microbiol Immunol. 2007;316:167-92
17969448
Hepatology. 2008 Apr;47(4):1136-49
18220274
FEBS Lett. 2004 Mar 12;561(1-3):117-21
15013761